@misc{indiciae1143807bddb0,
  title = {Daraxonrasib (RMC-6236) is an effective targeted therapy for RAS-mutant neuroblastoma},
  author = {Faber, A. C. and Floros, K. V. and Dozmorov, M. and Koblinski, J. and Lorenz, M. R. and Kraskauskiene, V. and Hu, B. and Zhang, K. and Kehinde, V. and Xing, Y. and Roberts, J. and Slaughter, J. M. and Kurupi, R. and Dalton, K. M. and Hill, R. D.},
  year = {2026},
  doi = {10.64898/2026.02.19.706849},
  url = {https://www.biorxiv.org/content/10.64898/2026.02.19.706849v1},
  note = {Source identifier: 10.64898/2026.02.19.706849}
}